Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Dow
Healthtrust
Mallinckrodt
Fuji
McKesson
McKinsey
Daiichi Sankyo
US Army

Generated: May 28, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,803,046

« Back to Dashboard

Which drugs does patent 6,803,046 protect, and when does it expire?

Patent 6,803,046 protects KINEVAC and is included in one NDA.

This patent has ten patent family members in eight countries.
Summary for Patent: 6,803,046
Title: Sincalide formulations
Abstract:The invention features sincalide formulations that include an effective amount of sincalide, a bulking agent/tonicity adjuster, a stabilizer, a surfactant, a chelator, and a buffer. The invention also features kits and methods for preparing improved sincalide formulations, as well as methods for treating, preventing, and diagnosing gall bladder-related disorders using sincalide formulations.
Inventor(s): Metcalfe; Edmund C. (Hillsborough, NJ), Monteferrante; Jo Anna (Raritan Township, NJ), Newborn; Margaret (Hamilton Township, NJ), Ropiak; Irene (Lawrenceville, NJ), Schramm; Ernst (North Brunswick, NJ), White; Gregory W. (Monmouth Junction, NJ), Zodda; Julius P. (Mercerville, NJ)
Assignee: Bracco International B.V. (Amsterdam, NL)
Application Number:10/222,540
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,803,046
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form; Use; Device;

Drugs Protected by US Patent 6,803,046

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Bracco KINEVAC sincalide INJECTABLE;INJECTION 017697-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Cipla
McKesson
Harvard Business School
Accenture
Healthtrust
Julphar
US Army
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.